AG
AUPH icon

Algert Global’s Aurinia Pharmaceuticals AUPH Stock Holding History

Algert Global’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-128,013
Closed -$938K – 1173
2024
Q3 		$938K Sell
128,013
-65,791
-34% -$408K 0.03% 759
2024
Q2 		$1.11M Buy
193,804
+100,104
+107% +$527K 0.04% 658
2024
Q1 		$469K Buy
+93,700
New +$636K 0.02% 777
2023
Q4 		– Sell
-52,939
Closed -$411K – 1129
2023
Q3 		$411K Buy
52,939
+11,240
+27% +$110K 0.02% 806
2023
Q2 		$404K Hold
41,699
– – 0.02% 851
2023
Q1 		$457K Buy
41,699
+15,829
+61% +$139K 0.02% 848
2022
Q4 		$112K Hold
25,870
– – 0.01% 1063
2022
Q3 		$195K Buy
+25,870
New +$224K 0.01% 1039

Other funds holding AUPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Algert Global's AUPH Position: Q4 2024 in Review

Algert Global sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2024, closing a stake of 128,013 shares — an estimated $938K sold.

Algert Global first reported a position in AUPH in Q3 2022 and held it in 8 quarters. The position peaked at $1.11M in Q2 2024. 200 funds tracked by Wall St. Rank hold AUPH as of Q4 2024.

  • Algert Global reported no remaining Aurinia Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Algert Global sold 128,013 Aurinia Pharmaceuticals shares in Q4 2024, an estimated $938K.
  • Algert Global first reported a position in Aurinia Pharmaceuticals in Q3 2022 and held it in 8 quarters.
  • Algert Global's Aurinia Pharmaceuticals position peaked at $1.11M in Q2 2024.
  • 200 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2024.

Based on Algert Global's 13F filing for Q4 2024, filed 14 Feb 2025.